Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOTROPIC PRESCRIBING INFORMATION
PSYCHOTROPIC DOSAGE RANGES
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
WE KNOW PSYCHIATRY
FEATURED ARTICLES
Home
David C. Steffens, MD, MHS: Cholesterol-Lowering Medication and Relapse of Depression
David C. Steffens, MD, MHS: Cholesterol-Lowering Medication and Relapse of Depression
$
30.00
David C. Steffens, MD, MHS: Cholesterol-Lowering Medication and Relapse of Depression quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 37 No. 4 Articles
Tags:
cholesterol
,
david-c-steffens
,
depression
,
douglas-r-mcquoid
,
elderly
,
k-ranga-rama-krishnan
,
medication
,
relapse
,
vascular
Description
Description
David C. Steffens, MD, MHS
PSYCHIATRIC COMORBIDITIES
Cholesterol-Lowering Medication and Relapse of Depression
David C. Steffens, MD, MHS, Douglas R. McQuoid, BS, and K. Ranga Rama Krishnan, MB, ChB
Share On Facebook
Tweet This Product
Pin This Product
Email This Product
Related products
In Vivo Neuroimaging Correlates of the Efficacy of Paroxetine in the Treatment of Mood and Anxiety Disorders
$
30.00
Add to cart
Details
Optimizing Treatment Outcomes for Patients With Depression and Generalized Anxiety Disorder
$
30.00
Add to cart
Details
Remission as the Critical Outcome of Depression Treatment
$
30.00
Add to cart
Details
Assessment of Anxiety in Clinical Trials with Depressed Patients
$
30.00
Add to cart
Details
Page load link
Go to Top
